Savient Pharmaceuticals Inc (NASDAQ:SVNT)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

0
Player Avatar pchop123 (76.64) Submitted: 8/31/2012 11:52:28 AM : Underperform Start Price: $1.37 SVNT Score: -3.28

Stock has run up a little BUT profitability is not on the horizon

Featured Broker Partners


Advertisement